BARCLAYS PLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$77
+196.2%
46,511
+251.6%
0.00%
Q2 2023$26
+550.0%
13,230
+561.5%
0.00%
Q1 2023$4
+33.3%
2,0000.0%0.00%
Q4 2022$3
-99.8%
2,0000.0%0.00%
Q3 2022$2,0000.0%2,0000.0%0.00%
Q2 2022$2,0000.0%2,0000.0%0.00%
Q1 2022$2,0002,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,470,332$8,967,0006.83%
Psagot Value Holdings Ltd. 470,255$1,707,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 212,591$772,0000.02%
UBS OCONNOR LLC 150,000$544,000,0000.01%
GSA CAPITAL PARTNERS LLP 10,042$36,0000.01%
Renaissance Technologies 488,634$1,774,0000.00%
Squarepoint Ops LLC 22,068$80,0000.00%
BANK OF AMERICA CORP /DE/ 222$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 50,280$183,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders